最新一代锥形束CT在肝动脉化疗栓塞术后碘油成像中的价值:与多排CT对比
结果显示CBCT评估碘油分布与MDCT相当,图像质量、对比噪声比及肿瘤体积测量均无显著差异,且能即时发现非靶栓塞和血肿等并发症。
要点
- CBCT评估碘油分布与MDCT相当(评分3.4 vs 3.2,p=0.29),可术中即时判断栓塞效果。
- CBCT与MDCT图像质量主观评分无显著差异(3.2 vs 3.1,p=0.15),CNR亦相当。
- CBCT肿瘤体积测量与T2加权MRI一致(27.0 vs 25.9 mm³,p=0.66),支持术中疗效评估。
关键影像表现/征象
- CBCT评估碘油分布的适用性平均评分3.4±1.0,MDCT为3.2±0.6,两者相当(p=0.29)。
- CBCT主观整体图像质量平均评分3.2±0.7(κ=0.66),MDCT为3.1±0.4(κ=0.57),无显著差异(p=0.15)。
- LLC评分CBCT为3.6±1.2,MDCT为2.6±1.5,两者有显著差异。
- CNR均值CBCT为3.5±1.3,MDCT为3.4±1.8,无显著差异(p=0.31)。
- CBCT未遗漏任何cTACE相关并发症(出血、非靶栓塞),与术后MDCT相比。
诊断标准与关键数值
- 主观图像质量和碘油分布适用性采用4分Likert量表评估(1-4分,分数越高越好)。
- 肿瘤体积测量:CBCT为27.0±17.4 mm³,MDCT为26.8±16.0 mm³,T2加权MRI为25.9±17.6 mm³,三者无显著差异(p=0.66)。
- 有效剂量:CBCT为3.2±0.6 mSv,MDCT为2.5±0.3 mSv,CBCT剂量显著高于MDCT(p<0.001)。
局限性
- 回顾性研究设计。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate image quality, radiation dose (phantom study) and tumor volumetry of intraprocedural cone-beam computed tomography (CBCT) compared to postprocedural multidetector computed tomography (MDCT) in patients undergoing hepatic conventional transarterial chemoembolization (cTACE).
MATERIALS AND METHODS: One hundred fourteen patients (64/50 female/male; mean age, 57 ± 14 years) who had undergone cTACE including intraprocedural-CBCT and postprocedural-MDCT were retrospectively enrolled. Subjective image quality (IQ) and suitability for assessing Lipiodol distribution were compared using 4-point Likert scales; additionally, lesion to liver contrast (LLC) and contrast-to-noise-ratio (CNR) were compared. Tumor volumes were measured semi-automatically and compared to magnetic resonance imaging (MRI). Effective doses were measured using an anthropomorphic phantom.
RESULTS: The suitability of CBCT for assessing Lipiodol distribution during cTACE was comparable to MDCT (mean score, 3.2 ± 0.6) and CBCT (3.4 ± 1.0, p = 0.29). Subjective overall IQ was rated with a mean score of 3.2 ± 0.7 (κ = 0.66) in CBCT and 3.1 ± 0.4 (κ = 0.57, p = 0.15) in MDCT. Evaluation of LLC showed significant differences between CBCT and MDCT (mean scores 3.6 ± 1.2 and 2.6 ± 1.5, respectively). CNR analysis demonstrated comparable mean values for CBCT and MDCT (3.5 ± 1.3 vs. 3.4 ± 1.8, p = 0.31). No significant differences were found regarding tumor volumetry (mean volumes: CBCT, 27.0 ± 17.4 mm3; MDCT: 26.8 ± 16.0 mm3; p = 0.66) in comparison to T2-weighted MRI (25.9 ± 17.6 mm3). Effective doses were 3.2 ± 0.6 mSv (CBCT) and 2.5 ± 0.3 mSv (MDCT) (p < 0.001). No cTACE-related complications (bleeding, non-target embolization) were missed on intraprocedural CBCT in comparison to postprocedural MDCT.
CONCLUSION: Latest-generation intraprocedural CBCT provides suitable assessment of Lipiodol distribution and similar image quality compared to MDCT while allowing for robust volumetric tumor measurements and immediate complication control by visualizing non-target embolization and hematoma. Therefore, it may improve patient safety and outcome as well as clinical workflow compared to postprocedural MDCT in hepatic cTACE in certain cases.
引用
- Alizadeh LS, Koch V, Vogl TJ, et al. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography. Acad Radiol. 2021. PMID: 34598867. doi:10.1016/j.acra.2021.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。